Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Cuker

Showing results (131-140 of 258) with videos related to

Pageof 26
Sort By:
Blood Advances|September 2, 2022
Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysisMia Djulbegovic, Jiayi Tong, Alice Xu, et al.
Annals of Hematology|July 18, 2022
Thrombopoietin receptor agonist discontinuation rates and reasons among patients with immune thrombocytopenia: a study of administrative claims linked with medical chart reviewAdam Cuker, Lincy Lal, Anuja Roy, et al.
Journal of the American College of Cardiology|July 9, 2016
Management of Periprocedural Anticoagulation: A Survey of Contemporary PracticeGreg C Flaker, Paul Theriot, Lea G Binder, et al.
Annals of Internal Medicine|March 29, 2021
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort StudyGhadeer K Dawwas, Eric Dietrich, Adam Cuker, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2024
The impact of obesity on chronic pain in patients with haemophilia: A multicentre retrospective analysisKeerthy Joseph, Adam Cuker, Skye Peltier, et al.
Blood|April 21, 2025
Rapid ADAMTS13 activity assays for thrombotic thrombocytopenic purpura: a systematic review and meta-analysisSaarang R Deshpande, Hemza Tarawneh, Chloe Cate Deitelzweig, et al.
Blood|April 18, 2024
Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United StatesChristina Waldron, Satoko Ito, Daniel Wang, et al.
British Journal of Haematology|February 18, 2022
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US studyHanny Al-Samkari, Debbie Jiang, Terry Gernsheimer, et al.
Scientific Reports|June 29, 2022
Comparability of clinical trials and spontaneous reporting data regarding COVID-19 vaccine safetyChongliang Luo, Jingcheng Du, Adam Cuker, et al.
American Journal of Hematology|March 28, 2019
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation ForumAdam Cuker, Allison Burnett, Darren Triller, et al.
Pageof 26

Showing results (131-140 of 258) with videos related to

Sort By:
Pageof 26
Blood Advances|September 2, 2022
Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysisMia Djulbegovic, Jiayi Tong, Alice Xu, et al.
Annals of Hematology|July 18, 2022
Thrombopoietin receptor agonist discontinuation rates and reasons among patients with immune thrombocytopenia: a study of administrative claims linked with medical chart reviewAdam Cuker, Lincy Lal, Anuja Roy, et al.
Journal of the American College of Cardiology|July 9, 2016
Management of Periprocedural Anticoagulation: A Survey of Contemporary PracticeGreg C Flaker, Paul Theriot, Lea G Binder, et al.
Annals of Internal Medicine|March 29, 2021
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort StudyGhadeer K Dawwas, Eric Dietrich, Adam Cuker, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2024
The impact of obesity on chronic pain in patients with haemophilia: A multicentre retrospective analysisKeerthy Joseph, Adam Cuker, Skye Peltier, et al.
Blood|April 21, 2025
Rapid ADAMTS13 activity assays for thrombotic thrombocytopenic purpura: a systematic review and meta-analysisSaarang R Deshpande, Hemza Tarawneh, Chloe Cate Deitelzweig, et al.
Blood|April 18, 2024
Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United StatesChristina Waldron, Satoko Ito, Daniel Wang, et al.
British Journal of Haematology|February 18, 2022
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US studyHanny Al-Samkari, Debbie Jiang, Terry Gernsheimer, et al.
Scientific Reports|June 29, 2022
Comparability of clinical trials and spontaneous reporting data regarding COVID-19 vaccine safetyChongliang Luo, Jingcheng Du, Adam Cuker, et al.
American Journal of Hematology|March 28, 2019
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation ForumAdam Cuker, Allison Burnett, Darren Triller, et al.
Pageof 26